ロード中...

The Benzopyrone Biochanin-A as a reversible, competitive, and selective monoamine oxidase B inhibitor

BACKGROUND: Monoamine oxidase-B (MAO-B) inhibitors are widely used in the treatment of Parkinson’s disease. They increase vital monoamine neurotransmitters in the brain. However, there is a need for safer natural reversible MAO inhibitors with MAO-B selectivity. Our previous studies showed that Psor...

詳細記述

保存先:
書誌詳細
出版年:BMC Complement Altern Med
主要な著者: Zarmouh, Najla O., Eyunni, Suresh K., Soliman, Karam F. A.
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2017
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5223566/
https://ncbi.nlm.nih.gov/pubmed/28069007
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12906-016-1525-y
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!